← Back to Search

Learning Strategies for Naming in Aphasia

Phase 2
Recruiting
Led By William Evans, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.
History of other acquired or progressive neurological disease.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial assessment (pre-treatment), multiple timepoints up to 6-months post-treatment.
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at new treatments to improve language skills for those with aphasia, a disorder caused by stroke or brain injury, & help them use them in everyday life.

Who is the study for?
This trial is for people who have had a stroke at least 6 months ago, resulting in chronic aphasia, which is difficulty with language and naming things. They must struggle on certain parts of a language test but can't have severe comprehension issues or other neurological diseases, unmanaged substance dependence, or serious mood disorders.
What is being tested?
The study tests three ways to help people with aphasia improve their ability to name pictures and use these skills in daily life. It compares treatments that focus on maximum effort, balance between effort and accuracy, and maximum accuracy using speeded naming tasks.
What are the potential side effects?
Since this trial involves non-medical interventions focused on learning strategies rather than drugs or surgery, traditional side effects are not expected. Participants may experience fatigue or frustration during the learning tasks.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a severe mood or behavioral disorder that needs special mental health care.
Select...
I have a history of a progressive neurological condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial assessment (pre-treatment), multiple timepoints up to 6-months post-treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial assessment (pre-treatment), multiple timepoints up to 6-months post-treatment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in correct responses in Confrontation Naming of Treated and Untreated Pictured Objects
Change in correct responses in Context Generalization of Treated and Untreated Pictured Objects
Secondary study objectives
Change in core lexicon analysis on the Aphasia Bank Discourse Protocol
Change in mean scores on the Aphasia Communication Outcome Measure Short-Form
Mean score on the Cactus and Camels Test (CCT)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Group I: Effort-maximized, then effort-accuracy balanced, then accuracy-maximizedExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group II: Effort-maximized, then accuracy-maximized, then effort-accuracy balancedExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group III: Effort-accuracy balanced, then effort-maximized, then accuracy maximizedExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group IV: Effort-accuracy balanced, then accuracy-maximized, then effort-maximizedExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group V: Accuracy-maximized, then effort-maximized, then effort-accuracy balancedExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group VI: Accuracy-maximized, then effort-accuracy balanced, then effort-maximizedExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,359,593 Total Patients Enrolled
3 Trials studying Aphasia
68 Patients Enrolled for Aphasia
University of Massachusetts, AmherstOTHER
81 Previous Clinical Trials
468,120 Total Patients Enrolled
2 Trials studying Aphasia
56 Patients Enrolled for Aphasia
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
354 Previous Clinical Trials
181,702 Total Patients Enrolled
39 Trials studying Aphasia
2,791 Patients Enrolled for Aphasia

Media Library

Accuracy-maximized condition Clinical Trial Eligibility Overview. Trial Name: NCT05653440 — Phase 2
Aphasia Research Study Groups: Effort-accuracy balanced, then accuracy-maximized, then effort-maximized, Effort-accuracy balanced, then effort-maximized, then accuracy maximized, Effort-maximized, then effort-accuracy balanced, then accuracy-maximized, Accuracy-maximized, then effort-maximized, then effort-accuracy balanced, Effort-maximized, then accuracy-maximized, then effort-accuracy balanced, Accuracy-maximized, then effort-accuracy balanced, then effort-maximized
Aphasia Clinical Trial 2023: Accuracy-maximized condition Highlights & Side Effects. Trial Name: NCT05653440 — Phase 2
Accuracy-maximized condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05653440 — Phase 2
~20 spots leftby Jan 2027